Gainers
- Nuvectis Pharma, Inc. (NASDAQ:NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share.
- Anghami Inc. (NASDAQ:ANGH) shares climbed 62.5% to close at $19.50 following its recent listing on NASDAQ.
- Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) surged 51.4% to settle at $1.62. Kaival Brands Innovations recently announced the U.S. Court of Appeals for the Eleventh Circuit has granted a judicial stay of the marketing denial order previously issued by the FDA to Bidi Vapor in September 2021.
- Origin Agritech Limited (NASDAQ:SEED) gained 34.5% to settle at $6.39 after the company said it expects FY22 sales to exceed RMB150 million.
- Bakkt Holdings, Inc. (NASDAQ:BKKT) shares jumped 34% to close at $5.80.
- Luokung Technology Corp. (NASDAQ:LKCO) gained 24.3% to close at $0.63. Luokung recently announced the receipt of Nasdaq notification regarding minimum bid price deficiency.
- Navidea Biopharmaceuticals, Inc. (NYSE:NAVB) surged 23.2% to settle at $0.8870 after the company announced a research agreement with the University of Pennsylvania evaluating Tc99m tilmanocept as a prognostic marker for glioblastoma.
- Peloton Interactive, Inc. (NASDAQ:PTON) gained 20.9% to close at $29.75 following a report from the Wall Street Journal that e-commerce giant Amazon.com Inc (NASDAQ:AMZN) has approached the connected fitness company about a potential acquisition.
- Castor Maritime Inc. (NASDAQ:CTRM) jumped 20.3% to close at $1.4550 after the company reported Q4 EPS results up from last year.
- Synthetic Biologics, Inc. (NYSE:SYN) surged 20% to settle at $0.2845.
- CF Acquisition Corp. VI (NASDAQ:CFVI) rose 18.2% to close at $15.09 following reports the company's merger partner Rumble has offered Joe Rogan $100 million over four years to join its platform.
- ContraFect Corporation (NASDAQ:CFRX) surged 18.2% to settle at $3.25. WBB Securities recently upgraded ContraFect from Speculative Buy to Buy and announced a $6.5 price target.
- Codex DNA, Inc. (NASDAQ:DNAY) climbed 17.7% to settle at $8.96.
- Lion Group Holding Ltd. (NASDAQ:LGHL) gained 17.5% to close at $0.9752.
- Spirit Airlines, Inc. (NYSE:SAVE) climbed 17.2% to close at $25.46 after the company announced a merger agreement with Frontier Group. The company also reported better-than-expected Q4 EPS and sales results.
- IceCure Medical Ltd (NASDAQ:ICCM) shares gained 17% to settle at $3.31. IceCure Medical recently said it sees preliminary FY21 revenues of $4.1 million.
- Iris Energy Limited (NASDAQ:IREN) surged 16.8% to close at $15.36.
- Phunware, Inc. (NASDAQ:PHUN) gained 16.5% to close at $2.96 after the company announced a strategic political partnership with Campaign Nucleus.
- Motorsport Games Inc. (NASDAQ:MSGM) surged 16.5% to close at $4.10.
- Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) gained 16.2% to settle at $6.54. Catalyst Pharmaceuticals anticipates Q4 FY21 sales of approximately $38 million (consensus of $38.09 million), up roughly 24% Y/Y.
- Express, Inc. (NYSE:EXPR) rose 14.6% to close at $3.93.
- NLS Pharmaceutics AG (NASDAQ:NLSP) gained 14.5% to settle at $1.04 after the Company announced to present interim topline data from its Phase 2a trial evaluating its lead product candidate, Quilience (Mazindol ER), for narcolepsy at World Sleep Congress 2022.
- Elevate Credit, Inc. (NASDAQ:ELVT) gained 13% to close at $3.47. Elevate is expected to report Q4 earnings on February 15, 2022.
- Tyson Foods, Inc. (NYSE:TSN) gained 12.2% to close at $99.09 after the company reported better-than-expected Q1 EPS and sales results.
- Singularity Future Technology Ltd. (NASDAQ:SGLY) gained 11% to settle at $6.08.
- Hut 8 Mining Corp. (NYSE:HUT) climbed 10.6% to close at $7.18 after jumping 12% on Friday.
- Senseonics Holdings, Inc. (NYSE:SENS) climbed 10.5% to close at $3.70. The company recently reiterated FY21 guidance.
- Bitfarms Ltd. (NASDAQ:BITF) climbed 8.9% to close at $4.15 after jumping around 12% on Friday.
- ON Semiconductor Corporation (NASDAQ:ON) climbed 8.4% to settle at $62.26 after the company reported better-than-expected Q4 EPS and sales results. The company also issued Q1 EPS and sales guidance above analyst estimates.
